| Product Code: ETC13165111 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Oncology NGS Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Oncology NGS Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 North America Oncology NGS Market - Industry Life Cycle |
3.4 North America Oncology NGS Market - Porter's Five Forces |
3.5 North America Oncology NGS Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 North America Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 North America Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.10 North America Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 North America Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Oncology NGS Market Trends |
6 North America Oncology NGS Market, 2021 - 2031 |
6.1 North America Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Oncology NGS Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 North America Oncology NGS Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.2 North America Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Oncology NGS Market, Revenues & Volume, By Diagnostics and Screening, 2021 - 2031 |
6.2.3 North America Oncology NGS Market, Revenues & Volume, By Research Studies, 2021 - 2031 |
6.3 North America Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Oncology NGS Market, Revenues & Volume, By Platforms and Related Products, 2021 - 2031 |
6.3.3 North America Oncology NGS Market, Revenues & Volume, By Services, 2021 - 2031 |
6.4 North America Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
6.4.2 North America Oncology NGS Market, Revenues & Volume, By Pre-Sequencing, 2021 - 2031 |
6.4.3 North America Oncology NGS Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.4.4 North America Oncology NGS Market, Revenues & Volume, By NGS Data Analysis, 2021 - 2031 |
6.5 North America Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Oncology NGS Market, Revenues & Volume, By Academic Research, 2021 - 2031 |
6.5.3 North America Oncology NGS Market, Revenues & Volume, By Clinical Research, 2021 - 2031 |
6.5.4 North America Oncology NGS Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.5.5 North America Oncology NGS Market, Revenues & Volume, By Pharma & Biotech Entities, 2021 - 2031 |
6.5.6 North America Oncology NGS Market, Revenues & Volume, By Other users, 2021 - 2031 |
7 North America Oncology NGS Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 United States (US) Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Canada Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Rest of North America Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 North America Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.1 United States (US) Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.2 Canada Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.3 Rest of North America Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.5 North America Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.1 United States (US) Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.2 Canada Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.3 Rest of North America Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.6 North America Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.1 United States (US) Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.2 Canada Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.3 Rest of North America Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 North America Oncology NGS Market Key Performance Indicators |
9 North America Oncology NGS Market - Export/Import By Countries Assessment |
10 North America Oncology NGS Market - Opportunity Assessment |
10.1 North America Oncology NGS Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 North America Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
10.5 North America Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10.6 North America Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 North America Oncology NGS Market - Competitive Landscape |
11.1 North America Oncology NGS Market Revenue Share, By Companies, 2022 |
11.2 North America Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here